INTELLIGENT BIO SOLUTIONS INC. Amortization of Intangible Assets
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Amortization of Intangible Assets of $1.15 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-19
- INTELLIGENT BIO SOLUTIONS INC. amortization of intangible assets for the quarter ending 2026-06-30 was $482.30K, a 106.02% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. amortization of intangible assets for the quarter ending 2026-03-31 was $215.64K, a 9.75% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. amortization of intangible assets for the quarter ending 2025-12-31 was $212.23K, a 11.86% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. amortization of intangible assets for the quarter ending 2025-09-30 was $242.37K, a 2.93% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. amortization of intangible assets for fiscal 2026 was $1.15M, a 21.41% increase from fiscal 2025.
- INTELLIGENT BIO SOLUTIONS INC. amortization of intangible assets for fiscal 2025 was $949.29K, a 0.20% increase from fiscal 2024.
- INTELLIGENT BIO SOLUTIONS INC. amortization of intangible assets for fiscal 2024 was $947.44K, a 17.58% increase from fiscal 2023.
- INTELLIGENT BIO SOLUTIONS INC. amortization of intangible assets for fiscal 2023 was $805.76K.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $482.30K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | $697.94K derived: sum of 2 quarters · filed 2026-08-19 | $910.17K derived: sum of 3 quarters · filed 2026-08-19 | $1.15M 10-K · filed 2026-08-19 | |||
| 2026-03-31 | $215.64K 10-Q · filed 2026-05-13 | $427.87K derived: sum of 2 quarters · filed 2026-05-13 | $670.24K 10-Q · filed 2026-05-13 | $904.34K derived: sum of 4 quarters · filed 2026-08-19 | |||
| 2025-12-31 | $212.23K 10-Q · filed 2026-02-12 | $454.60K 10-Q · filed 2026-02-12 | $688.69K derived: sum of 3 quarters · filed 2026-08-19 | $927.64K derived: sum of 4 quarters · filed 2026-08-19 | |||
| 2025-09-30 | $242.37K 10-Q · filed 2025-11-12 | $476.46K derived: sum of 2 quarters · filed 2026-08-19 | $715.41K derived: sum of 3 quarters · filed 2026-08-19 | $956.19K derived: sum of 4 quarters · filed 2026-08-19 | |||
| 2025-06-30 | $234.10K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | $473.04K derived: sum of 2 quarters · filed 2026-08-19 | $713.82K derived: sum of 3 quarters · filed 2026-08-19 | $949.29K 10-K · filed 2026-08-19 | |||
| 2025-03-31 | $238.94K 10-Q · filed 2026-05-13 | $479.73K derived: sum of 2 quarters · filed 2026-05-13 | $715.19K 10-Q · filed 2026-05-13 | $936.46K derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | $240.78K 10-Q · filed 2026-02-12 | $476.25K 10-Q · filed 2026-02-12 | $697.51K derived: sum of 3 quarters · filed 2026-02-12 | $952.99K derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2024-09-30 | $235.46K 10-Q · filed 2025-11-12 | $456.73K derived: sum of 2 quarters · filed 2025-11-12 | $712.20K derived: sum of 3 quarters · filed 2025-11-12 | $939.75K derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $221.27K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-15 | $476.74K derived: sum of 2 quarters · filed 2025-08-15 | $704.28K derived: sum of 3 quarters · filed 2025-08-15 | $947.44K 10-K · filed 2025-08-15 | |||
| 2024-03-31 | $255.47K 10-Q · filed 2025-05-13 | $283.71K 10-Q · filed 2024-05-08 | $483.01K derived: sum of 2 quarters · filed 2025-05-13 | $726.17K 10-Q · filed 2025-05-13 | $845.36K derived: sum of 4 quarters · filed 2025-05-13 | ||
| 2023-12-31 | $227.54K 10-Q · filed 2025-02-13 | $267.26K 10-Q · filed 2024-02-09 | $470.70K 10-Q · filed 2025-02-13 | $442.46K 10-Q · filed 2024-02-09 | $589.89K derived: sum of 3 quarters · filed 2025-02-13 | $936.44K derived: sum of 4 quarters · filed 2025-02-13 | |
| 2023-09-30 | $243.15K 10-Q · filed 2024-11-07 | $175.20K 10-Q · filed 2023-11-08 | $362.35K derived: sum of 2 quarters · filed 2024-11-07 | $708.89K derived: sum of 3 quarters · filed 2024-11-07 | $1.05M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | $119.19K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-18 | $465.74K derived: sum of 2 quarters · filed 2024-09-18 | $805.76K derived: sum of 3 quarters · filed 2024-09-18 | $805.76K 10-K · filed 2024-09-18 | $850.78K 10-K · filed 2023-08-23 | ||
| 2023-03-31 | $346.55K 10-Q · filed 2024-05-08 | $686.57K derived: sum of 2 quarters · filed 2024-05-08 | $686.57K 10-Q · filed 2024-05-08 | $686.57K derived: sum of 4 quarters · filed 2024-05-08 | |||
| 2022-12-31 | $340.02K 10-Q · filed 2024-02-09 | $340.02K 10-Q · filed 2024-02-09 | $340.02K derived: sum of 3 quarters · filed 2024-02-09 | $340.02K derived: sum of 4 quarters · filed 2024-02-09 | |||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $0.00 derived: sum of 3 quarters · filed 2023-11-08 | $0.00 derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2022-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | $0.00 derived: sum of 2 quarters · filed 2023-08-23 | $0.00 derived: sum of 3 quarters · filed 2023-08-23 | $0.00 10-K · filed 2023-08-23 | |||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | $0.00 derived: sum of 2 quarters · filed 2023-05-11 | $0.00 10-Q · filed 2023-05-11 | ||||
| 2021-12-31 | $0.00 10-Q · filed 2023-02-14 | $0.00 10-Q · filed 2023-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |